Lumiliximab (Anti-FceR2 / CD23)
A2501
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameLumiliximab (Anti-FceR2 / CD23)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionLumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203